Clinical Trial Update: Once Weekly Parathyroid Hormone for Osteoporosis [Phase 3]

View source ↗

Summary

Phase 3 study evaluating once-weekly parathyroid hormone for osteoporosis has completed, according to this clinical trial update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteopenia
• Osteoporosis

Drugs mentioned

• Parathyroid hormone (Parathyroid hormone)

Snippet

Sponsor: University of California, San Francisco | Conditions: Osteopenia, Osteoporosis | Phase 3 | Status: COMPLETED